找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Chemoradiation in Cancer Therapy; Hak Choy Book 2003 Springer Science+Business Media New York 2003 breast cancer.cancer.carcinoma.chemothe

[复制链接]
查看: 48094|回复: 60
发表于 2025-3-21 16:27:15 | 显示全部楼层 |阅读模式
书目名称Chemoradiation in Cancer Therapy
编辑Hak Choy
视频videohttp://file.papertrans.cn/225/224930/224930.mp4
概述Includes supplementary material:
丛书名称Cancer Drug Discovery and Development
图书封面Titlebook: Chemoradiation in Cancer Therapy;  Hak Choy Book 2003 Springer Science+Business Media New York 2003 breast cancer.cancer.carcinoma.chemothe
描述Internationally recognized experts in cancer biology and clinical research review the present status of the multimodality approach to the management of solid tumors and speculate on possible future strategies for chemoradiation therapy. The authors detail applications of combined modality therapy in lung, esophageal, breast, gastric, pancreatic, colon, and rectal cancers. They also show how radiation interacts with such chemotherapeutic agents as the platinum complexes, taxanes, and gemcitabine in the treatment of malignant gliomas, and head and neck cancer. A review of how to integrate new specific molecular targeted agents into multimodality therapy in the future.
出版日期Book 2003
关键词breast cancer; cancer; carcinoma; chemotherapy; gene therapy; radiation; radiotherapy; tumor
版次1
doihttps://doi.org/10.1007/978-1-59259-325-5
isbn_softcover978-1-61737-313-8
isbn_ebook978-1-59259-325-5Series ISSN 2196-9906 Series E-ISSN 2196-9914
issn_series 2196-9906
copyrightSpringer Science+Business Media New York 2003
The information of publication is updating

书目名称Chemoradiation in Cancer Therapy影响因子(影响力)




书目名称Chemoradiation in Cancer Therapy影响因子(影响力)学科排名




书目名称Chemoradiation in Cancer Therapy网络公开度




书目名称Chemoradiation in Cancer Therapy网络公开度学科排名




书目名称Chemoradiation in Cancer Therapy被引频次




书目名称Chemoradiation in Cancer Therapy被引频次学科排名




书目名称Chemoradiation in Cancer Therapy年度引用




书目名称Chemoradiation in Cancer Therapy年度引用学科排名




书目名称Chemoradiation in Cancer Therapy读者反馈




书目名称Chemoradiation in Cancer Therapy读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 22:03:27 | 显示全部楼层
发表于 2025-3-22 03:00:21 | 显示全部楼层
发表于 2025-3-22 06:34:04 | 显示全部楼层
发表于 2025-3-22 09:20:07 | 显示全部楼层
发表于 2025-3-22 14:39:29 | 显示全部楼层
The Role of Gemcitabine in Combined Modality Therapyon in pancreatic carcinoma, gemcitabine has been licensed for the treatment of nonsmall-cell lung cancer (NSCLC) .. The focus of this chapter will be to examine the current preclinical and clinical evidence probing the efficacy of gemcitabine as a clinically useful radiosensitizing agent. It will be
发表于 2025-3-22 17:47:45 | 显示全部楼层
发表于 2025-3-23 01:13:48 | 显示全部楼层
Combined Modality Strategies in the Treatment of Head and Neck Cancerr Society estimates that in the United States alone approx 40,300 new cases of HNC will be diagnosed annually with approx 11,700 deaths associated from this disease .. If cured, HNC patients are at increased risk of developing a second malignancy, estimated to occur at an annual incidence of 3–7% (3
发表于 2025-3-23 01:53:39 | 显示全部楼层
The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Cancer 131,000 new cases of nonsmall-cell lung cancer (NSCLC) diagnosed in 2000 will die from their disease .. The focus of this chapter is on the patients who present with locally advanced or stage III NSCLC (about 46,000 patients yearly). Although it is tempting to think of stage III NSCLC as a uniform
发表于 2025-3-23 07:37:28 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-25 12:13
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表